Key Person Insurance
Venture Capital Requirement:
What VCs Demand and Why
A VC does not write a $5 million check without protecting the asset that justifies the valuation. That asset is you. Before a Series A closes, institutional investors require a key person insurance policy with the company — not your family — named as beneficiary. This post breaks down the term sheet language, how to size the policy against your cap table, and what happens to your round if you get this structure wrong.
1. The Business Logic Behind the VC Requirement
When an institutional investor commits capital to an early-stage company, they are not buying a diversified asset with observable market pricing. They are underwriting a specific thesis about a specific team’s ability to execute on a specific opportunity within a specific window. At the seed and Series A stage, that thesis is frequently inseparable from one or two individuals who hold the technical architecture in their heads, the customer relationships in their networks, or the regulatory expertise that makes the product viable at all. Remove that individual from the equation and the thesis does not merely weaken. For many early-stage companies, it collapses entirely.
Key person insurance is the investor’s mechanism for converting that binary human capital risk into a manageable financial event. The policy does not replace the founder. No policy can do that. What it does is fund the four to twelve months of business continuity, executive search, customer relationship maintenance, and operational bridge that gives the company the best available chance of surviving the founder’s loss without a forced liquidation that destroys investor capital. From the VC’s perspective, the annual premium on a $5 million key person policy for a portfolio company founder is an extraordinarily cheap hedge against the total loss of a $4 million to $8 million investment.
2. The Term Sheet Clause: What It Says and What It Means
Key person insurance requirements appear in venture term sheets in several locations depending on the investor’s preferred documentation structure. They most commonly appear as a closing condition in the Stock Purchase Agreement, as an affirmative covenant in the Investor Rights Agreement, or as a standalone post-closing deliverable with a specified cure period. Understanding exactly what the language obligates the company to do, and when, is essential for founders and their counsel to avoid a covenant default at the worst possible time.
3. Sizing the Policy: Three Methods VCs Use to Set the Required Face Value
The face value specified in a term sheet key person insurance clause is not arbitrary. Institutional investors use one of three sizing methodologies, and understanding which methodology your investor is applying allows founders to evaluate whether the required face value is commercially reasonable and to negotiate it intelligently if it is not. Each method produces a different face value for the same founder at the same company, and the differences can be substantial.
4. Key Person Insurance Requirements by Funding Stage
The key person insurance requirement evolves as a company progresses through funding rounds. What is optional at pre-seed becomes expected at seed, required at Series A, and financially significant at Series B and beyond. Understanding the typical requirement at each stage allows founders to plan ahead rather than scramble during due diligence.
5. Corporate-Owned Life Insurance: The Structure Founders Must Understand
The key person insurance policy required by institutional investors is not a personal life insurance policy with the company added as a secondary beneficiary. It is a corporate-owned life insurance contract in which the company is the exclusive owner, the exclusive premium payer, and the exclusive beneficiary. This distinction has significant implications for the founder’s personal estate plan, the company’s tax treatment of premiums, the treatment of the policy on the balance sheet, and the handling of the policy when the founder departs. Getting this structure wrong at the point of policy application creates problems that are difficult and expensive to correct later.
| Feature | Key Person COLI (VC Requirement) | Personal Life Insurance (Founder’s Own) |
|---|---|---|
| Policy owner | The Company — owns all rights including surrender, assignment, and loan | The Founder / Insured — retains full ownership and portability |
| Premium payer | The Company — premiums paid from operating funds; not deductible | The Founder — paid from personal funds; also not deductible for individuals |
| Beneficiary | The Company — 100% of death benefit flows to company; founder’s family receives nothing from this policy | Founder’s Family / Estate — proceeds distributed per beneficiary designation |
| IRC Section 101(j) consent | Required — employer-owned life insurance requires written notice and signed consent from the insured employee before policy is issued | Not applicable — individual policies not subject to IRC 101(j) |
| Death benefit taxation | Tax-free to the company if IRC 101(j) notice and consent requirements are met; partially taxable if requirements are not met | Tax-free to beneficiaries under IRC Section 101(a) in virtually all cases |
| Balance sheet treatment | Permanent COLI policies: cash value recorded as long-term asset; term policies: expense only, no asset | Not recorded on company balance sheet |
| What happens when founder leaves | Company retains ownership. Policy can be surrendered, transferred to founder via separation agreement (with VC consent), or maintained as corporate asset | Founder retains the policy fully; no company involvement |
| What VC controls | Lead investor covenant typically requires investor consent to terminate, assign, or modify policy terms | VC has no rights or visibility into personal life insurance |
Corporate-owned life insurance policies on non-owner employees are subject to IRC Section 101(j), which requires the employer to provide the insured employee with written notice that the employer intends to insure their life, the maximum face value of the policy, and that the employer will be the beneficiary — and to receive the employee’s written consent before the policy is issued. If the notice and consent requirements are not met before policy issuance, the death benefit in excess of the employer’s basis in the policy becomes taxable income to the company when the insured dies. On a $5 million key person policy, the tax consequence of this failure can exceed $1.7 million at current corporate rates. Most insurance brokers experienced in COLI placements handle the 101(j) compliance documentation automatically, but founders should confirm this step is in their broker’s standard process and retain a copy of the signed consent form in the company’s legal records.
Calculate Your Key Person Policy Face Value Before the Term Sheet Lands
Our Key Person Insurance Valuation Calculator applies all three sizing methods to your specific revenue, compensation, and investment structure and shows which method governs your required face value.
6. The Cap Table Protection Logic: What Happens to Investor Equity Without the Policy
The most direct way to understand why institutional investors require key person insurance is to model the cap table outcome in a founder loss scenario with and without a funded business continuity plan. The difference between these two scenarios is not a matter of degree. It is frequently the difference between a managed succession that preserves the company and a forced liquidation that destroys investor capital at a fraction of its potential value.
Cap Table and Investor Outcome Without a Funded Business Continuity Plan
Cap Table and Investor Outcome With a Funded Business Continuity Plan
7. Negotiating the Key Person Covenant: What Founders Can and Cannot Change
Most founders accept key person insurance covenants without negotiation because they assume the terms are non-negotiable. In practice, several covenant terms are routinely negotiated by experienced startup counsel, and understanding which terms are flexible versus which are firm positions on the investor side allows founders to use negotiating capital efficiently.
| Covenant Term | Investor’s Standard Position | Negotiability | Founder’s Leverage Point |
|---|---|---|---|
| Policy face value | 1 to 2 times lead investor check size, or per sizing method | Moderate | Use the replacement cost method output as the negotiating anchor if it produces a lower face value — and document the calculation methodology in the negotiation record |
| Covered persons | CEO and CTO at minimum; all co-founders preferred by many investors | Moderate | If a co-founder has a minimal operational role, argue for exclusion based on low revenue and IP contribution. Investors typically accept this with updated title and role documentation |
| Post-closing delivery window | 30 days is standard | High | Request 45 to 60 days if a covered founder has a known medical condition that may extend underwriting. Most investors grant this with a documented underwriting timeline from the broker |
| Company as sole beneficiary | Non-negotiable for properly structured COLI | None | This term cannot be changed and should not be contested. Any attempt to split the beneficiary between the company and the founder’s family signals to the investor that the founder misunderstands the purpose of the policy |
| Termination requires investor consent | Majority preferred stock approval required to terminate or assign | Low to Moderate | Negotiate for a sunset provision at a specific revenue or headcount milestone — e.g., termination approval right lapses when company reaches $10M ARR or replaces founders with institutional management team |
| Policy type (term vs. permanent) | Term policy is standard and acceptable at Series A | High | Founders can choose between term and permanent without investor objection in most cases — permanent policy builds cash value as a balance sheet asset, which some investors prefer at growth stage |
| Departure policy transfer terms | Company retains policy; transfer to departing founder requires investor consent | Moderate | Negotiate a right-of-first-offer at book value for the departing founder to purchase the policy, exercisable within 90 days of departure, as part of the initial investment documents rather than leaving it to a separation negotiation |
8. The D&O Insurance Intersection: Why Key Person and Directors Coverage Must Be Coordinated
Key person insurance and Directors and Officers liability insurance are both required by institutional investors and both appear in venture term sheets, but they cover categorically different risks and interact in ways that founders and board members frequently misunderstand. Failing to coordinate the two policies can create coverage gaps at the moment of a claim — when the events that trigger a key person claim (founder incapacitation or death) are frequently the same events that trigger D&O claims by disgruntled investors or shareholders alleging inadequate succession planning.
| Feature | Key Person Insurance | Directors and Officers (D&O) Insurance |
|---|---|---|
| What it covers | Financial loss to the company from death or disability of a specified individual whose loss impairs business operations or investor capital | Personal liability of directors and officers for wrongful acts in their management capacity, including securities claims, breach of fiduciary duty, and employment practices claims |
| Who it protects | The company (as entity) and by extension the investors whose capital is at risk from the company’s impaired operations | Individual directors and officers personally — their personal assets are protected from claims arising from their management decisions |
| Trigger event | Death or permanent disability of the insured key person — a factual event requiring death certificate or disability determination | A claim or demand alleging a wrongful act by a covered director or officer — a legal event requiring a claim to be formally asserted |
| Proceeds flow to | The company — used for business continuity, executive search, and operational bridge | The individual director or officer (or their defense counsel directly) — used to fund their legal defense and settlement |
| Where overlap occurs | When a founder’s death or incapacitation triggers both a key person claim AND a shareholder derivative suit alleging the board failed to maintain adequate succession planning. The key person proceeds are received by the company while D&O covers the defense costs of the board members sued for the succession planning failure. Both policies activate simultaneously on different coverage lanes. | |
| Required review | Ensure the key person policy does not have a cross-liability exclusion that reduces the benefit when the company is simultaneously a defendant in related litigation | Ensure the D&O policy does not exclude claims arising from events covered under another policy — some D&O policies have other insurance clauses that interact with COLI coverage |
9. The Founder Implementation Checklist: From Term Sheet to Policy Delivery in 30 Days
The 30-day post-closing delivery window for key person insurance is tight but achievable if the process is started during due diligence rather than after closing. The checklist below is designed for founders working with a commercial insurance broker experienced in COLI placements for venture-backed companies — not a consumer life insurance agent, who will lack the institutional documentation experience needed for this specific policy structure.
Key person insurance for venture-backed companies requires a broker who understands COLI structure, IRC Section 101(j) compliance documentation, institutional investor covenant requirements, and the evidence of coverage format that VC legal counsel will accept. General consumer life insurance agents are not equipped to handle this placement. Engage a commercial broker through your startup legal counsel’s network or through the VC firm’s portfolio operations team, which typically maintains a recommended broker list for exactly this requirement.
If the term sheet covers both the CEO and CTO, both applications must be submitted simultaneously to avoid a situation where one founder’s policy is delayed by medical underwriting while the closing deadline is running. The application requires the insured’s full legal name, date of birth, Social Security number, current health history, existing life insurance in force, and the company’s federal tax identification number as the policy owner. For face values above $1 million, most carriers require a medical exam for insureds under age 60. Schedule the medical exam for the earliest available date — typically 1 to 2 weeks from application submission.
Before the policy is issued, the company must provide each insured founder with a written notice document stating: (i) the company intends to insure the founder’s life under an employer-owned life insurance contract, (ii) the maximum face value of the policy, (iii) that the company will be the sole beneficiary, and (iv) that the founder’s consent is voluntary. The founder must sign and return the consent acknowledgment. This document is retained in the company’s permanent legal records. Your commercial broker will provide the standard 101(j) notice and consent forms — do not use a self-drafted version, as the IRS has specific language requirements for this disclosure to be effective.
The medical exam for key person policies covering face values above $1 million includes a physical examination, blood draw, urinalysis, and for insureds over 40, an EKG and additional screenings. The insurer’s underwriting team reviews the exam results alongside the application and assigns a risk classification (Preferred Plus, Preferred, Standard Plus, Standard, or substandard table ratings) that determines the final premium. If either covered founder receives a substandard table rating, the broker should immediately request competing quotes from alternative carriers before the closing deadline — table ratings vary significantly between insurers for the same health profile.
Once the policy is issued and the first premium is paid, request a formal evidence of coverage letter from the insurer on letterhead confirming the policy number, face value, insured name, owner (the company), beneficiary (the company), and policy effective date. This letter is the document your investor’s counsel needs to confirm the closing condition has been satisfied. Deliver the evidence of coverage letter to your lead investor’s legal counsel by email with a read receipt before Day 30 of the closing condition window, and retain a copy in the company’s board resolution records alongside the signed 101(j) consent documentation.
Size Your Key Person Policy Before the Term Sheet Lands
Our Key Person Insurance Valuation Calculator applies the invested capital protection, revenue contribution, and replacement cost methods to your specific numbers and shows you the face value your VC will require — before negotiations begin.
Open Policy Sizer →Frequently Asked Questions
Do VCs require key person insurance in term sheets?
Yes, institutional venture capital investors frequently require key person insurance as a closing condition in Series A and later term sheets, particularly for companies where one or two founders represent the primarytechnical, commercial, or network relationships that drive the business. The requirement is typically structured as a covenant in the investment agreement obligating the company to maintain a key person policy of a specified minimum face value — commonly 1 to 2 times the investment amount — with the company named as sole beneficiary. Failure to maintain the required policy is typically a covenant default that can trigger investor protective provisions including board seat adjustments or drag-along rights.
How is key person insurance policy size calculated for a venture-backed startup?
Key person insurance policy size for a venture-backed startup is calculated using one of three methods. The replacement cost method estimates the total cost to recruit, onboard, and ramp a replacement executive — typically 2 to 4 times the key person’s annual fully-loaded compensation. The revenue contribution method calculates the key person’s direct revenue attribution and applies a 12 to 18 month multiplier. The invested capital protection method sets the policy face value at 1 to 2 times the cumulative capital invested by the lead investor. For most Series A deals, all three methods produce a face value in the range of $2 million to $10 million, and the highest result governs the required face value in most institutional term sheets.
Who is the beneficiary of key person insurance in a startup?
In a properly structured key person insurance policy for a venture-backed startup, the company — not the founder’s family — is the named beneficiary and policy owner. This is a corporate-owned life insurance structure in which the company pays the premiums, owns the policy asset, and receives the death benefit proceeds. The founder’s family receives no proceeds from the key person policy. This structure is required by institutional investors because the policy purpose is to protect the company’s operational continuity and preserve investor capital, not to provide personal financial protection for the insured’s household. Founders should maintain a separate personal life insurance policy for their family’s financial protection.
What happens to the key person insurance policy if the founder leaves?
When a founder leaves the company voluntarily or is removed, the company retains ownership of the key person COLI policy because the company is the policy owner and premium payer. The policy can then be surrendered for cash value if it is a permanent policy, assigned to the departing founder as part of a negotiated separation agreement subject to investor consent, or maintained as a corporate asset. Founders negotiating a separation agreement should explicitly address key person policy ownership and assignment as part of the negotiated terms. Most institutional investor covenants require lead investor consent before the policy can be transferred to a departing founder, giving investors meaningful influence over this aspect of founder exit negotiations.
Is key person insurance tax deductible for a startup?
No. Key person insurance premiums are not tax deductible for the company when the company is the direct or indirect beneficiary of the policy, per IRS rules under IRC Section 264. Premiums are paid from after-tax operating funds and treated as a non-deductible business expense. However, the death benefit proceeds received by the company are generally received income-tax-free under IRC Section 101(a), provided the policy qualifies as an employer-owned life insurance contract under IRC Section 101(j) notice and consent requirements. Failure to comply with the 101(j) requirements causes the death benefit to become partially taxable, eliminating a significant portion of the financial protection the policy was designed to provide.
Do VCs require key person insurance in term sheets?
Yes, institutional venture capital investors frequently require key person insurance as a closing condition in Series A and later term sheets, particularly for companies where one or two founders represent the primary technical, commercial, or network relationships that drive the business. The requirement is typically structured as a covenant in the investment agreement obligating the company to maintain a key person policy of a specified minimum face value — commonly 1 to 2 times the investment amount — with the company named as sole beneficiary. The VC firm does not receive the insurance proceeds directly; rather, the proceeds flow to the company to fund business continuity, executive recruiting, and bridge operations while a successor is identified. Failure to maintain the required policy is typically a covenant default that can trigger investor protective provisions including board seat adjustments or drag-along rights.
How is key person insurance policy size calculated for a venture-backed startup?
Key person insurance policy size for a venture-backed startup is calculated using one of three methods, and institutional investors typically specify which method applies in the term sheet. The replacement cost method estimates the total cost to recruit, onboard, and ramp a replacement executive to full productivity — typically 1.5 to 3 times the key person’s annual fully-loaded compensation for technical founders, and 2 to 4 times for revenue-generating commercial founders. The revenue contribution method calculates the key person’s direct revenue attribution and applies a multiple based on the company’s current revenue run rate — typically 12 to 18 months of their contributed revenue. The invested capital protection method sets the policy face value at 1 to 2 times the cumulative capital invested by the lead investor to ensure the business can return or preserve investor capital in a worst-case scenario. For most Series A deals, the result of all three methods produces a policy face value in the range of $2 million to $10 million.
Who is the beneficiary of key person insurance in a startup?
In a properly structured key person insurance policy for a venture-backed startup, the company — not the founder’s family — is the named beneficiary and policy owner. This is a corporate-owned life insurance (COLI) structure in which the company pays the premiums, owns the policy asset, and receives the death benefit proceeds. The founder’s family receives no proceeds from the key person policy. This structure is categorically different from personal life insurance, where the insured’s family is the beneficiary. The COLI structure is required by institutional investors because the policy purpose is to protect the company’s operational continuity and preserve investor capital, not to provide personal financial protection for the insured’s household. Founders maintaining both a key person policy and separate personal life insurance should ensure the two policies are clearly distinguished in their estate planning documents and that the insurable interest disclosure is correctly documented for the COLI policy.
What happens to the key person insurance policy if the founder leaves the company voluntarily?
If a founder leaves the company voluntarily — whether through resignation, removal by the board, or a buyout — the key person insurance policy treatment depends on how the policy ownership and assignment terms were drafted. In most COLI structures, the company retains ownership of the policy after the insured founder departs, because the company is both the policy owner and the premium payer. The policy can then be either surrendered for cash value if it is a permanent policy, assigned to the departing founder as part of a negotiated separation agreement, or maintained as a corporate asset if the insurable interest doctrine allows continuation after departure. In many states, insurable interest must exist at the time the policy is issued but does not need to continue for the policy to remain in force. However, founders negotiating a separation agreement should explicitly address key person policy ownership and assignment as part of the negotiated terms, as failure to do so can leave a departing founder insured under a policy owned and controlled by a company they no longer lead.
